This suggests that Mettl3 exerts its regulatory effects on pancreatic cancer through the modulation of these genes.[72] Spermine synthase (SMS) has been identified as a downstream target of both Mettl3 and IGF2BP3. The gene discussed is METTL3; the disease is familial pancreatic carcinoma.